Rory B Riggs is Director of Royalty Pharma plc. Currently has a direct ownership of 320,099 shares of RPRX, which is worth approximately $7.98 Million. The most recent transaction as insider was on Feb 20, 2024, when has been sold 300,000 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K
0% 3M change
34.69% 12M change
Total Value Held $7.98 Million

RORY B RIGGS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
BUY
Conversion of derivative security
-
300,000 Added 48.38%
320,099 Class A Ordinary Shares
Jan 04 2024
SELL
Open market or private sale
$983,590 $27.55 p/Share
35,702 Reduced 63.98%
20,099 Class A Ordinary Shares
Jan 03 2024
SELL
Open market or private sale
$5,532,933 $27.79 p/Share
199,098 Reduced 78.11%
55,801 Class A Ordinary Shares
Jan 02 2024
SELL
Open market or private sale
$6,707,904 $28.52 p/Share
235,200 Reduced 47.99%
254,899 Class A Ordinary Shares
Nov 13 2023
BUY
Conversion of derivative security
-
475,590 Added 49.25%
490,099 Class A Ordinary Shares
Jun 23 2023
BUY
Grant, award, or other acquisition
-
7,747 Added 34.81%
14,509 Class A Ordinary Shares
May 22 2023
SELL
Open market or private sale
$57,435,000 $32.82 p/Share
1,750,000 Reduced 99.62%
6,762 Class A Ordinary Shares
May 09 2023
BUY
Conversion of derivative security
-
300,000 Added 14.59%
1,756,762 Class A Ordinary Shares
Mar 30 2023
SELL
Open market or private sale
$4,714,670 $36.26 p/Share
130,024 Reduced 8.19%
1,456,762 Class A Ordinary Shares
Mar 29 2023
SELL
Open market or private sale
$366,765 $36.95 p/Share
9,926 Reduced 0.62%
1,586,786 Class A Ordinary Shares
Feb 17 2023
BUY
Conversion of derivative security
-
1,500,000 Added 48.44%
1,596,712 Class A Ordinary Shares
Dec 09 2022
SELL
Open market or private sale
$840,979 $42.07 p/Share
19,990 Reduced 12.76%
136,722 Class A Ordinary Shares
Nov 17 2022
SELL
Open market or private sale
$5,079,600 $42.33 p/Share
120,000 Reduced 43.37%
156,712 Class A Ordinary Shares
Sep 15 2022
SELL
Open market or private sale
$2,195,975 $42.21 p/Share
52,025 Reduced 15.83%
276,712 Class A Ordinary Shares
Sep 14 2022
SELL
Open market or private sale
$2,034,620 $42.41 p/Share
47,975 Reduced 12.74%
328,737 Class A Ordinary Shares
Aug 09 2022
SELL
Open market or private sale
$1,967,850 $43.73 p/Share
45,000 Reduced 10.67%
376,712 Class A Ordinary Shares
Jun 29 2022
SELL
Open market or private sale
$1,265,100 $42.17 p/Share
30,000 Reduced 6.64%
421,712 Class A Ordinary Shares
May 20 2022
SELL
Open market or private sale
$4,858,779 $39.28 p/Share
123,696 Reduced 21.5%
451,712 Class A Ordinary Shares
May 19 2022
SELL
Open market or private sale
$1,054,527 $40.09 p/Share
26,304 Reduced 4.37%
575,408 Class A Ordinary Shares
Mar 29 2022
SELL
Open market or private sale
$2,315,400 $38.59 p/Share
60,000 Reduced 9.07%
601,712 Class A Ordinary Shares
Mar 17 2022
BUY
Other acquisition or disposition
-
68,964 Added 9.44%
661,712 Class A Ordinary Shares
Dec 29 2021
SELL
Open market or private sale
$3,000,000 $40.0 p/Share
75,000 Reduced 11.23%
592,748 Class A Ordinary Shares
Dec 28 2021
BUY
Other acquisition or disposition
-
45,350 Added 6.36%
667,748 Class A Ordinary Shares
Nov 17 2021
SELL
Open market or private sale
$2,646,620 $42.39 p/Share
62,435 Reduced 9.12%
622,398 Class A Ordinary Shares
Nov 16 2021
SELL
Open market or private sale
$527,856 $42.01 p/Share
12,565 Reduced 1.8%
684,833 Class A Ordinary Shares

Also insider at

ITCI
Intra-Cellular Therapies, Inc. Healthcare
FGEN
FIBROGEN INC Healthcare
CLXT
Calyxt, Inc. Consumer Defensive
RBR

Rory B Riggs

Director
New York, NY

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Track Activities on RPRX